Bevacizumab and irinotecan in children with recurrent or refractory brain tumors: toxicity and efficacy trends. (Q48685934)
Jump to navigation
Jump to search
scientific article published on 27 January 2012
Language | Label | Description | Also known as |
---|---|---|---|
English | Bevacizumab and irinotecan in children with recurrent or refractory brain tumors: toxicity and efficacy trends. |
scientific article published on 27 January 2012 |
Statements
1 reference
Bevacizumab and irinotecan in children with recurrent or refractory brain tumors: toxicity and efficacy trends. (English)
1 reference
Franck Bourdeaut
1 reference
Isabelle Aerts
1 reference
Marie-Laure Couec
1 reference
Nicolas André
1 reference
Estelle Thebaud
1 reference
Odile Minckes
1 reference
Xavier Rialland
1 reference
Nadège Corradini
1 reference
Perrine Marec BĂ©rard
1 reference
Pierre Leblond
1 reference
Comité Pharmacologie of the SFCE
1 reference
27 January 2012
1 reference
59
1 reference
1
1 reference
34-38
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference